chr16-1459139-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001287.6(CLCN7):c.643G>A(p.Gly215Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001287.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN7 | NM_001287.6 | c.643G>A | p.Gly215Arg | missense_variant | 7/25 | ENST00000382745.9 | NP_001278.1 | |
CLCN7 | NM_001114331.3 | c.571G>A | p.Gly191Arg | missense_variant | 6/24 | NP_001107803.1 | ||
CLCN7 | XM_011522354.2 | c.469G>A | p.Gly157Arg | missense_variant | 7/25 | XP_011520656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN7 | ENST00000382745.9 | c.643G>A | p.Gly215Arg | missense_variant | 7/25 | 1 | NM_001287.6 | ENSP00000372193 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460772Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726622
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 06, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 215 of the CLCN7 protein (p.Gly215Arg). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects CLCN7 function (PMID: 15111300). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN7 protein function. ClinVar contains an entry for this variant (Variation ID: 65635). This missense change has been observed in individuals with autosomal dominant osteopetrosis (PMID: 11741829). This variant is not present in population databases (gnomAD no frequency). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 25, 2024 | Published functional studies demonstrate reduced transport of chloride across the membrane suggesting a damaging effect on acidification during bone resorption (PMID: 19543743); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26325626, 14584882, 15111300, 19070589, 24336069, 20830208, 24185277, 31231577, 11741829, 27540713, 19953639, 23744590, 19288050, 26395888, 17164308, 36999084, 19543743) - |
Autosomal dominant osteopetrosis 2 Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Lab, Department of Haematology, Christian Medical College | May 20, 2022 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
CLCN7-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 23, 2023 | The CLCN7 c.643G>A variant is predicted to result in the amino acid substitution p.Gly215Arg. This variant has been reported in multiple individuals with autosomal dominant osteopetrosis and was reported to segregate with disease in at least one family (Table 1, Cleiren et al. 2001. PubMed ID: 11741829; Figure 1, Piret et al. 2016. PubMed ID: 27540713; Figure 3, Chen et al. 2023. PubMed ID: 36999084). In vitro experimental studies suggest this variant inhibits protein function and impacts the osteoclast acidification process (Figure 5, Henriksen et al. 2004. PubMed ID: 15111300; Figure 5, Kajiya et al. 2009. PubMed ID: 19543743). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at